Zenosense, Inc. MIDS Cardiac Bench Reader Development

Press Release VALENCIA, SPAIN–(Marketwired – Oct 31, 2016) –  Zenosense, Inc. (OTCQB: ZENO) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialization of MIDS Cardiac™, a Point of Care (“POC”) handheld device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis, treatment and disposition…

Zenosense, Inc. General Update – Cardiac Device Development

VALENCIA, SPAIN–(Marketwired – Sep 19, 2016) –  Zenosense, Inc. ( OTC PINK : ZENO ) (“Zenosense”, the “Company”), a healthcare technology company primarily focused on the development and commercialisation of MIDS Cardiac™, a Point of Care (“POC”) hand held device for the early detection of certain cardiac event biomarkers to significantly accelerate the triage, diagnosis,…